Ranibizumab injection 0.3 mg

DRUG2 trials

Sponsors

Genentech, Inc.

Conditions

Macular EdemaRetinal Vein Occlusion

Phase 3

A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO)

CompletedNCT00486018

Genentech, Inc.Macular Edema, Retinal Vein Occlusion

Start: 2007-07-31End: 2009-11-30Updated: 2017-05-10

A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE)

CompletedNCT00485836

Genentech, Inc.Macular Edema, Retinal Vein Occlusion

Start: 2007-07-31End: 2009-12-31Updated: 2017-07-28

Related Papers

Reading speed improvements in retinal vein occlusion after ranibizumab treatment.

2013-07-0121 citations